HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Post-operative Nausea and Analgesia Following Total Mastectomy is Improved After Implementation of an Enhanced Recovery Protocol.

AbstractBACKGROUND:
Enhanced Recovery Protocols (ERPs) provide a multimodal approach to perioperative care, with the aims of improving patient outcomes while decreasing perioperative antiemetic and narcotic requirements. With high rates of post-operative nausea or vomiting (PONV) following total mastectomy (TM), we hypothesized that our institutional designed ERP would reduce PONV while improving pain control and decrease opioid use.
METHODS:
An ERP was implemented at a single institution for patients undergoing TM with or without implant-based reconstruction. Patients from the first two months of implementation (ERP group, N = 72) were compared with a retrospective usual-care cohort from a three-month period before implementation (UC group, N = 83). Outcomes included PONV incidence, measured with antiemetic use; patient-reported pain scores; perioperative opioid consumption, measured by oral morphine equivalents (OME); and length of stay (LOS).
RESULTS:
The characteristics of the two groups were similar. PONV incidence and perioperative opioid consumption were lower in the ERP than the UC group (21% vs. 40%, p 0.011 and mean 44.1 OME vs. 104.3 OME, p < 0.001), respectively. These differences in opioid consumption were observed in the operating room and post-anesthesia care unit (PACU); opioid consumption on the floor was similar between the two groups. Patient-reported pain scores were lower in the ERP than the UC group (mean highest pain score 6.4 vs. 7.4, p 0.003). PACU and hospital LOS were similar between the two groups.
CONCLUSION:
ERP implementation was successful in decreasing PONV following TM with and without reconstruction, while simultaneously decreasing overall opioid consumption without compromising patient comfort.
AuthorsKate H Dinh, Priscilla F McAuliffe, Michael Boisen, Stephen A Esper, Kathirvel Subramaniam, Jennifer G Steiman, Atilla Soran, Ronald R Johnson, Jennifer M Holder-Murray, Emilia J Diego
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 27 Issue 12 Pg. 4828-4834 (Nov 2020) ISSN: 1534-4681 [Electronic] United States
PMID32748151 (Publication Type: Journal Article)
Chemical References
  • Analgesics, Opioid
Topics
  • Analgesia
  • Analgesics, Opioid (therapeutic use)
  • Breast Neoplasms (surgery)
  • Humans
  • Mastectomy (adverse effects)
  • Pain
  • Pain, Postoperative (drug therapy, etiology, prevention & control)
  • Postoperative Nausea and Vomiting (epidemiology, etiology, prevention & control)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: